1383686-30-3

Basic information

• Product Name: (2-bromophenyl)-dicyclohexylphosphine borane
• Synonyms: (2-bromophenyl)-dicyclohexylphosphine borane
• CAS NO: 1383686-30-3
• Molecular Weight: 367.117
• Mol File: 1383686-30-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (2-bromophenyl)-dicyclohexylphosphine borane(CAS DataBase Reference)
• NIST Chemistry Reference: (2-bromophenyl)-dicyclohexylphosphine borane(1383686-30-3)
• EPA Substance Registry System: (2-bromophenyl)-dicyclohexylphosphine borane(1383686-30-3)

Safety Data

• Hazardous Substances Data: 1383686-30-3(Hazardous Substances Data)

Upstream product

• 829-84-5 dicyclohexylphosphane 
• 108756-88-3 (dicyclohexylphosphino)borane 
• 583-53-9 2,3-dibromobenzene 

Downstream Products

• 2241598-34-3 (R)-N-((S)-(3,5-di-tert-butyl-4-methoxyphenyl)(2-(dicyclohexylphosphanyl)phenyl)methyl)-N,2-dimethylpropane-2-sulfinamide 
• 1417911-75-1 dicyclohexyl-(2-dicyclohexylboranyl-phenyl)phosphine borane 
• 1417911-72-8 dicyclohexyl-[2-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]phosphine borane 
• 1384459-06-6 (2'-bromo-2'',6''-dimethoxy[1,1';3',1'']terphenyl-2-yl)dicyclohexylphosphine borane 

Relevant articles and documents

Sequential Pd0- and PdII-Catalyzed Cyclizations: Enantioselective Heck and Nucleopalladation Reactions

An enantioselective consecutive cyclization/coupling process, catalyzed by palladium is reported. Stereoinduction arises from an enantioselective carbopalladation, generating an intermediate which promotes a nucleopalladation step. The dual cyclization se

P-CHIROGENIC ORGANOPHOSPHORUS COMPOUNDS

The present invention relates to novel P-chirogenic organophosphorus compounds of general formula (I). The present invention also provides a process for the synthesis of said compounds of formula (I). The present invention also relates to intermediate products of general formulae (II), (III) and (IV), as shown below, which are involved in the synthesis of compounds (I). Further, the invention relates to metal complexes comprising compounds (I) as ligands. The novel compounds and complexes of the present invention are useful in asymmetric catalysis by transition metal complexes or organocatalysis, especially for asymmetric hydrogenation or allylation. Compounds of general formula (I) may useful as agrochemical and therapeutic substances, or as reagents or intermediates for fine chemistry.